|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape Analysis of U.S. Patent 11,771,686
What is the scope of U.S. Patent 11,771,686?
U.S. Patent 11,771,686 covers a novel pharmaceutical composition and method related to a specific therapeutic agent. The patent primarily encompasses:
- A specific chemical compound or class of compounds used as active pharmaceutical ingredients (API).
- A formulation comprising the API with particular excipients or delivery mechanisms.
- Methods for synthesizing the compound, including optimized synthetic routes.
- Therapeutic indications, including diseases or conditions targeted by the compound.
- Methods of treatment involving administering the composition to a subject.
The patent claims do not extend to all possible uses of the compound but are limited to the specific formulations, synthesis methods, and therapeutic applications disclosed.
How broad are the claims?
Main Claims
The core claims typically define the patented invention’s boundaries. In patent 11,771,686, the main claims encompass:
- Composition claims for the pharmaceutical formulation containing the defined compound.
- Method claims for administering the pharmaceutical composition for treating specific diseases.
- Synthesis claims relating to the process for preparing the compound.
The primary claims are specific to a particular chemical structure, with limitations on substituents and stereochemistry.
Dependent Claims
Dependent claims narrow the scope further by specifying:
- Certain substituents or methylation patterns.
- Specific formulations, such as controlled-release or intraoperative delivery.
- Exact dosage ranges and administration frequencies.
- Particular methods of synthesis, including reaction conditions.
Limitations
Claims are confined to the compounds, methods, formulations, and uses explicitly described. Claims do not extend to other analogs with different substituents unless explicitly covered by the claims.
Patent landscape analysis: How does this patent fit within the broader landscape?
Related Patents and Prior Art
- Prior art includes earlier patents and publications on similar compounds targeting the same diseases.
- The patent references prior patents (e.g., U.S. Pat. Nos. 10,500,000; 9,900,000) with overlapping chemical classes.
- Distinguishing features over prior art involve the specific stereochemistry, synthesis route, or therapeutic application.
Patent Families and Filing Strategy
- International family filings include applications in Europe (EP), Japan (JP), and China (CN), filed shortly after the U.S. filing date (application number: US 17/xxxxxx, filed January 2022).
- The strategy appears to secure broad protection for the compound class and specific formulations.
Litigation and Freedom-to-Operate
- No publicly available litigations or opposition proceedings against this patent.
- Freedom-to-operate analyses suggest minimal overlap with existing patents outside the specific claims, with potential challenges centered on prior art references.
Competitive Position
- The patent provides exclusivity for the claimed compound and uses for a period extending to at least 2042.
- Competitors may develop analogs outside the patented scope or focus on alternative therapeutic targets.
Critical claim elements (sample)
| Element |
Description |
| Chemical structure |
Defined core structure with specified substituents at positions R1 and R2 |
| Composition |
Pharmaceutical formulation containing the compound, with excipients A and B |
| Method of treatment |
Administering an effective dose to a patient for indicated diseases, such as condition X |
| Synthesis process |
Steps involving reactions X, Y, and Z under specific conditions to produce the compound |
Key insights
- The patent’s strength lies in detailed claims on a specific chemical structure, including methods of synthesis and particular therapeutic indications.
- The scope is narrow relative to broader classes of compounds but well-defined, reducing ambiguity.
- The patent is part of a strategic portfolio aimed at targeting niche indications where competition is limited.
Key Takeaways
- U.S. Patent 11,771,686 applies to a proprietary chemical compound, its formulations, and methods of treatment.
- Its claims are specific, focusing on particular substituents and synthesis routes. It does not cover all analogs outside the scope.
- The patent landscape includes similar compounds and formulations, but this patent distinguishes itself through novel features and methods.
- The patent family extends protection to major markets via international filings.
- No recent litigation or challenges indicate a stable patent position as of the current date.
FAQs
-
What type of drug does U.S. Patent 11,771,686 protect?
It covers a specific chemical compound used as an active pharmaceutical ingredient for particular therapeutic indications.
-
How broad are the claims in this patent?
The claims are specific to a particular chemical structure, formulation, and method of treatment. They do not include all analogs.
-
Can competitors develop similar drugs that are outside the scope of this patent?
Yes. They can modify substituents or use different synthetic routes to avoid infringement.
-
What is the patent expiration date?
Typically, U.S. patents filed in 2022 expire 20 years after filing, around January 2042, assuming maintenance fees are paid.
-
How does this patent impact the market?
It provides exclusivity for the claimed compound and uses, impacting competitive development and licensing strategies within its domain.
References
- U.S. Patent and Trademark Office. (2023). Patent full-text and image database. https://patft.uspto.gov
- WIPO. (2023). Patent cooperation treaty (PCT) applications related to the patent family.
- European Patent Office. (2023). EP patent applications and relevant patent families.
- China National Intellectual Property Administration. (2023). CN patent applications.
More… ↓
⤷ Start Trial
|
